Invus
About Invus
Invus is an evergreen equity investor with over $10 billion under management, empowering leaders to transform their industries. They provide the freedom to take risks, capital to reach the prize, and advice to navigate uncharted waters.
Recent News
Recent Deals
Flexiv Raises Growth-Stage Funding From Invus to Accelerate Global Robot Deployment
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Triana Biomedicines Secures $120M Series B Funding Led by Ascenta Capital and Bessemer
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners